Table 1.
Candida albicans strains used in this study
| Strain | Genotype | References |
|---|---|---|
| RSY150 | TUB2-GFP-SAT1/TUB2_ HTB1-RFP-ARG4_/HTB1_ arg4_/_ | [35] |
| RSY35 | leu2::hisG/leu2::hisG his1::hisG/his1::hisG arg4::hisG/arg4::hisG kar3::LEU2/kar3::HIS1 TUB2/TUB2-GFP::SAT1 | [35] |
| CASS1 | his3::hisG/his3::hisGleu2::tetRGAL4AD-URA3/LEU2 | [37] |
| ATCC 64548 | Reference strain | Cedarlane Labs, Ontario, Canada |
| ATCC 10231 | Reference strain for clinical isolates | RQHR, Regina, |
| SK, Canada | ||
| C. albicans (1-4) | Clinical isolates; 2 blood, 2 genital | RQHR, Regina, SK, Canada |
| C. albicans knockout mutants | ||
| VPS28 | his3::hisG/his3::hisGleu2::tetRGAL4AD-URA3/LEU2-VPS28 | [37] |
| CRH11 | his3::hisG/his3::hisGleu2::tetRGAL4AD-URA3/LEU2-Crh11 | [37] |
| SSU81 | his3::hisG/his3::hisGleu2::tetRGAL4AD-URA3/LEU2-SSU81 | [37] |
| DFG5 | his3::hisG/his3::hisGleu2::tetRGAL4AD-URA3/LEU2-DGF5 | [37] |